The DAYBREAK-ALZ Study is a clinical research study in mild Alzheimer’s disease.

We are looking for people who would like to participate.

The study will examine an oral investigational medication that may have some effect on the

brain changes associated with Alzheimer’s disease. The study is designed to find out

whether this investigational medication (or” study medication”) can slow down the

decline in memory and mental functioning. ” Investigational” means that the medication

is still being evaluated in clinical studies, and has not yet been approved for use by doctors

in their everyday practice.

The DAYBREAK-ALZ study will include approximately 1,900 participants from around the globe.

Who can join the DAYBREAK-ALZ Study?

To join the study you must:

  • Be between 55 and 85 years old
  • Have experienced a gradual loss of memory over the last 6 months (the study team will assess whether this is due to Alzheimer’s disease)

OR

  • Have been diagnosed with mild Alzheimer’s disease
  • Have a close friend, relative or partner who would be willing to be your study partner throughout the study

Download Study Brochure

Download

Do you qualify to take part in our studies? Find Out Today

Register to take part

Daybreak Study